Fanny Franchini

2.9k total citations · 2 hit papers
27 papers, 2.1k citations indexed

About

Fanny Franchini is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Fanny Franchini has authored 27 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Immunology. Recurrent topics in Fanny Franchini's work include Cancer Genomics and Diagnostics (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Economic and Financial Impacts of Cancer (5 papers). Fanny Franchini is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Economic and Financial Impacts of Cancer (5 papers). Fanny Franchini collaborates with scholars based in Australia, United Kingdom and Netherlands. Fanny Franchini's co-authors include Fiona Powrie, Nathaniel R. West, Sarah McCuaig, Julie Schulthess, Isabelle C. Arnold, Nicholas E. Ilott, Stephen N. Sansom, Rose L. Szabady, Oliver J. Harrison and Emily Thornton and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Fanny Franchini

25 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages

2019 742 citations Julie Schulthess, Sumeet Pandey et al. Immunity profile →
Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model

2013 412 citations Stefanie Kirchberger, Daniel Royston et al. The Journal of Experimental Medicine profile →

Peers

Fanny Franchini

IMMUN

ONCOL

SURGE

Carlos H.F. Chan United States

Xiaohuan Guo China

Gwenny M. Fuhler Netherlands

Romain Daillère France

Anke Franzke Germany

Bertrand Routy Canada

Makoto Shioya Japan

Hafid O. Al‐Hassi United Kingdom

Petr Hrúz Switzerland

Hiroshi Tamagawa Japan

Carlos H.F. Chan United States

Fanny Franchini

621 ×0.7

501 ×0.6

IMMUN

555 ×1.0

ONCOL

472 ×1.3

SURGE

120 ×0.6

Citations per year, relative to Fanny Franchini Fanny Franchini (= 1×) peers Carlos H.F. Chan

Countries citing papers authored by Fanny Franchini

Since Specialization

Citations

This map shows the geographic impact of Fanny Franchini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanny Franchini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanny Franchini more than expected).

Fields of papers citing papers by Fanny Franchini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanny Franchini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanny Franchini. The network helps show where Fanny Franchini may publish in the future.

Co-authorship network of co-authors of Fanny Franchini

This figure shows the co-authorship network connecting the top 25 collaborators of Fanny Franchini. A scholar is included among the top collaborators of Fanny Franchini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanny Franchini. Fanny Franchini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Franchini, Fanny, et al.. (2025). Current and emerging opportunities for deintensification of systemic therapies in melanoma: A scoping review. European Journal of Cancer. 233. 116132–116132.

Mian, Firoz, et al.. (2024). Analysis of risk factors for immune-related adverse events induced by immune checkpoint inhibitor treatment in cancer: A comprehensive systematic review. Critical Reviews in Oncology/Hematology. 207. 104601–104601. 2 indexed citations

Mian, Firoz, et al.. (2024). Correction: Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review. British Journal of Cancer. 132(1). 137–137. 1 indexed citations

Mian, Firoz, et al.. (2024). Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review. British Journal of Cancer. 132(1). 51–57. 23 indexed citations

Yang, Ou, et al.. (2024). Effects of clinical and socioeconomic factors on Medicare and patient costs for colorectal cancer in Australia: a retrospective multivariate regression analysis. BMJ Open. 14(12). e081483–e081483.

Franchini, Fanny, Roma Shah, Marliese Alexander, et al.. (2024). Real-World Treatment and Outcomes in ALK-Rearranged NSCLC: Results From a Large U.S.-Based Database. JTO Clinical and Research Reports. 5(8). 100662–100662. 4 indexed citations

Franchini, Fanny, et al.. (2023). Implementing competing risks in discrete event simulation: the event-specific probabilities and distributions approach. Frontiers in Pharmacology. 14. 1255021–1255021. 1 indexed citations

Zhang, Jianrong, Maarten J. IJzerman, Rebecca J. Bergin, et al.. (2022). Time to diagnosis and treatment of lung cancer: A systematic overview of risk factors, interventions and impact on patient outcomes. Lung Cancer. 166. 27–39. 11 indexed citations

Degeling, Koen, Fanny Franchini, Ben Tran, et al.. (2022). Comparing Survival Outcomes for Advanced Cancer Patients Who Received Complex Genomic Profiling Using a Synthetic Control Arm. Targeted Oncology. 17(5). 539–548. 10 indexed citations

10.

Kang, Yoon‐Jung, Fanny Franchini, Maarten J. IJzerman, et al.. (2022). A scoping review and meta-analysis on the prevalence of pan-tumour biomarkers (dMMR, MSI, high TMB) in different solid tumours. Scientific Reports. 12(1). 20495–20495. 44 indexed citations

11.

Degeling, Koen, Nancy N. Baxter, Jon Emery, et al.. (2021). An inverse stage‐shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID‐19 pandemic. Asia-Pacific Journal of Clinical Oncology. 17(4). 359–367. 56 indexed citations

12.

Franchini, Fanny, Marliese Alexander, Susana Banerjee, et al.. (2021). Impact of COVID-19 on cancer service delivery: a follow-up international survey of oncology clinicians. ESMO Open. 6(5). 100224–100224. 8 indexed citations

13.

Im, Jae Hong, Jon N. Buzzelli, Keaton Jones, et al.. (2020). FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy. Nature Communications. 11(1). 4064–4064. 102 indexed citations

14.

Cui, Wanyuan, Fanny Franchini, Marliese Alexander, et al.. (2020). Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer. Lung Cancer. 146. 310–317. 41 indexed citations

15.

Schulthess, Julie, Sumeet Pandey, Melania Capitani, et al.. (2019). The Short Chain Fatty Acid Butyrate Imprints an Antimicrobial Program in Macrophages. Immunity. 50(2). 432–445.e7. 742 indexed citations breakdown →

16.

Ryzhakov, Grigory, Nathaniel R. West, Fanny Franchini, et al.. (2018). Alpha kinase 1 controls intestinal inflammation by suppressing the IL-12/Th1 axis. Nature Communications. 9(1). 3797–3797. 43 indexed citations

17.

Danne, Camille, Grigory Ryzhakov, María Martínez‐López, et al.. (2017). A Large Polysaccharide Produced by Helicobacter hepaticus Induces an Anti-inflammatory Gene Signature in Macrophages. Cell Host & Microbe. 22(6). 733–745.e5. 87 indexed citations

18.

West, Nathaniel R., Sarah McCuaig, Fanny Franchini, & Fiona Powrie. (2015). Emerging cytokine networks in colorectal cancer. Nature reviews. Immunology. 15(10). 615–629. 292 indexed citations

19.

Griseri, Thibault, Isabelle C. Arnold, Claire Pearson, et al.. (2015). Granulocyte Macrophage Colony-Stimulating Factor-Activated Eosinophils Promote Interleukin-23 Driven Chronic Colitis. Immunity. 43(1). 187–199. 149 indexed citations

20.

Kirchberger, Stefanie, Daniel Royston, Olivier Boulard, et al.. (2013). Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. The Journal of Experimental Medicine. 210(5). 917–931. 412 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact